Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, IONS, VRTX, ISRG, ALNY, and represent 22.53% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: EVH (+$28M), EXAS (+$20M), BMRN (+$20M), ABT (+$16M), INSP (+$15M), TNDM (+$13M), UNH (+$12M), SRPT (+$12M), IQV (+$8.9M), TERN (+$8.7M).
- Started 12 new stock positions in TERN, SNY, BNTX, SMMT, Summit Therapeutics, VCYT, NRIX, NAMS, BMY, ACLX. TVTX, DNLI.
- Reduced shares in these 10 stocks: BIO (-$37M), INSM (-$36M), ARGX (-$32M), CRL (-$31M), ALNY (-$31M), CNC (-$25M), CDNA (-$24M), Silk Road Medical Inc Common (-$23M), HCM (-$22M), ISRG (-$21M).
- Sold out of its positions in AAPL, ATRC, BCYC, CCCC, DVAX, ETNB, EXAI, FDMT, GRAL, NVRO. OM, Silk Road Medical Inc Common, TDOC, WST, ALKS.
- Bellevue Group was a net seller of stock by $-269M.
- Bellevue Group has $6.2B in assets under management (AUM), dropping by 0.30%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Bellevue Group
Bellevue Group holds 163 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Argenx Se Sponsored Adr (ARGX) | 5.6 | $343M | -8% | 633k | 542.08 |
|
Ionis Pharmaceuticals (IONS) | 5.1 | $315M | -4% | 7.9M | 40.06 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $266M | -3% | 571k | 465.08 |
|
Intuitive Surgical Com New (ISRG) | 4.0 | $244M | -7% | 497k | 491.27 |
|
Alnylam Pharmaceuticals (ALNY) | 3.6 | $223M | -12% | 809k | 275.03 |
|
Revolution Medicines (RVMD) | 3.6 | $221M | -3% | 4.9M | 45.35 |
|
Neurocrine Biosciences (NBIX) | 3.5 | $215M | 1.9M | 115.22 |
|
|
Boston Scientific Corporation (BSX) | 3.3 | $206M | -4% | 2.5M | 83.80 |
|
Abbott Laboratories (ABT) | 3.2 | $199M | +8% | 1.7M | 114.01 |
|
Stryker Corporation (SYK) | 3.1 | $190M | -3% | 527k | 361.26 |
|
Intra Cellular Therapies (ITCI) | 2.9 | $182M | 2.5M | 73.17 |
|
|
Agios Pharmaceuticals (AGIO) | 2.7 | $166M | -3% | 3.7M | 44.43 |
|
Incyte Corporation (INCY) | 2.3 | $142M | 2.2M | 66.10 |
|
|
UnitedHealth (UNH) | 2.1 | $132M | +9% | 226k | 584.68 |
|
Moderna (MRNA) | 1.7 | $107M | +2% | 1.6M | 66.83 |
|
Celldex Therapeutics Com New (CLDX) | 1.7 | $104M | +3% | 3.1M | 33.99 |
|
Biohaven (BHVN) | 1.7 | $102M | 2.0M | 49.97 |
|
|
EXACT Sciences Corporation (EXAS) | 1.6 | $99M | +25% | 1.4M | 68.12 |
|
Caredx (CDNA) | 1.6 | $98M | -19% | 3.1M | 31.23 |
|
Insulet Corporation (PODD) | 1.6 | $98M | -3% | 422k | 232.75 |
|
Medtronic SHS (MDT) | 1.5 | $91M | 1.0M | 90.03 |
|
|
Becton, Dickinson and (BDX) | 1.3 | $81M | -2% | 338k | 241.10 |
|
Tandem Diabetes Care Com New (TNDM) | 1.3 | $79M | +19% | 1.9M | 42.41 |
|
Evolent Health Cl A (EVH) | 1.2 | $76M | +59% | 2.7M | 28.28 |
|
Edwards Lifesciences (EW) | 1.2 | $75M | -10% | 1.1M | 65.99 |
|
Dex (DXCM) | 1.1 | $68M | -19% | 1.0M | 67.04 |
|
Arvinas Ord (ARVN) | 1.0 | $59M | 2.4M | 24.63 |
|
|
Penumbra (PEN) | 0.9 | $53M | -3% | 273k | 194.31 |
|
Relay Therapeutics (RLAY) | 0.8 | $52M | +15% | 7.4M | 7.08 |
|
Option Care Health Com New (OPCH) | 0.8 | $52M | +16% | 1.7M | 31.30 |
|
Ge Healthcare Technologies I Common Stock (GEHC) | 0.8 | $50M | +2% | 532k | 93.85 |
|
Procept Biorobotics Corp (PRCT) | 0.8 | $49M | -8% | 613k | 80.12 |
|
Essa Pharma Com New (EPIX) | 0.8 | $48M | 7.9M | 6.06 |
|
|
Zimmer Holdings (ZBH) | 0.8 | $47M | -3% | 433k | 107.95 |
|
Hca Holdings (HCA) | 0.8 | $47M | -6% | 115k | 406.43 |
|
Anthem (ELV) | 0.8 | $47M | -12% | 89k | 520.00 |
|
IDEXX Laboratories (IDXX) | 0.7 | $46M | -2% | 91k | 505.22 |
|
Cooper Cos (COO) | 0.7 | $44M | 397k | 110.34 |
|
|
Sarepta Therapeutics (SRPT) | 0.7 | $43M | +36% | 344k | 124.89 |
|
Exelixis (EXEL) | 0.7 | $42M | -11% | 1.6M | 25.95 |
|
Inspire Med Sys (INSP) | 0.7 | $41M | +56% | 195k | 211.05 |
|
Cigna Corp (CI) | 0.7 | $41M | -3% | 118k | 346.44 |
|
Eli Lilly & Co. (LLY) | 0.6 | $39M | -10% | 44k | 885.94 |
|
ResMed (RMD) | 0.6 | $39M | +2% | 160k | 244.12 |
|
Insmed Com Par $.01 (INSM) | 0.6 | $38M | -48% | 525k | 73.00 |
|
Edgewise Therapeutics (EWTX) | 0.6 | $38M | 1.4M | 26.69 |
|
|
Immunocore Hldgs Ads (IMCR) | 0.6 | $38M | +4% | 1.2M | 31.13 |
|
Beam Therapeutics (BEAM) | 0.6 | $37M | +7% | 1.5M | 24.50 |
|
Black Diamond Therapeutics (BDTX) | 0.6 | $37M | 8.5M | 4.35 |
|
|
Align Technology (ALGN) | 0.6 | $37M | 144k | 254.32 |
|
|
Castle Biosciences (CSTL) | 0.6 | $36M | +3% | 1.3M | 28.52 |
|
Verona Pharma Sponsored Ads (VRNA) | 0.6 | $35M | +7% | 1.2M | 28.77 |
|
Veeva Sys Cl A Com (VEEV) | 0.6 | $34M | -3% | 164k | 209.87 |
|
Globus Med Cl A (GMED) | 0.5 | $34M | -5% | 470k | 71.54 |
|
Wave Life Sciences SHS (WVE) | 0.5 | $34M | 4.1M | 8.20 |
|
|
Thermo Fisher Scientific (TMO) | 0.5 | $33M | +25% | 54k | 618.57 |
|
Axsome Therapeutics (AXSM) | 0.5 | $33M | -28% | 367k | 89.87 |
|
Macrogenics (MGNX) | 0.5 | $33M | 9.9M | 3.29 |
|
|
Sage Therapeutics (SAGE) | 0.5 | $32M | 4.5M | 7.22 |
|
|
Iqvia Holdings (IQV) | 0.5 | $31M | +40% | 130k | 236.97 |
|
Annexon (ANNX) | 0.5 | $31M | 5.2M | 5.92 |
|
|
Danaher Corporation (DHR) | 0.5 | $29M | +25% | 106k | 278.02 |
|
Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $29M | 610k | 46.98 |
|
|
Regeneron Pharmaceuticals (REGN) | 0.5 | $28M | -17% | 27k | 1051.24 |
|
Structure Therapeutics Sponsord Ads (GPCR) | 0.4 | $28M | +12% | 630k | 43.89 |
|
Transmedics Group (TMDX) | 0.4 | $27M | -15% | 170k | 157.00 |
|
Neogenomics Com New (NEO) | 0.4 | $24M | +34% | 1.6M | 14.75 |
|
Molina Healthcare (MOH) | 0.4 | $23M | -11% | 68k | 344.56 |
|
BioMarin Pharmaceutical (BMRN) | 0.4 | $23M | +533% | 331k | 70.29 |
|
Steris Shs Usd (STE) | 0.4 | $22M | 91k | 242.54 |
|
|
Hologic (HOLX) | 0.3 | $20M | 248k | 81.46 |
|
|
Si-bone (SIBN) | 0.3 | $20M | +4% | 1.4M | 13.98 |
|
Privia Health Group (PRVA) | 0.3 | $19M | 1.1M | 18.21 |
|
|
McKesson Corporation (MCK) | 0.3 | $18M | -22% | 36k | 494.42 |
|
Natera (NTRA) | 0.3 | $18M | -35% | 139k | 126.95 |
|
Scholar Rock Hldg Corp (SRRK) | 0.3 | $17M | 2.2M | 8.01 |
|
|
Fate Therapeutics (FATE) | 0.3 | $17M | 4.8M | 3.50 |
|
|
Esperion Therapeutics (ESPR) | 0.3 | $16M | 9.9M | 1.65 |
|
|
AmerisourceBergen (COR) | 0.3 | $16M | -19% | 72k | 225.08 |
|
Bio Rad Labs Cl A (BIO) | 0.3 | $15M | -70% | 46k | 334.58 |
|
Astrana Health Com New (ASTH) | 0.2 | $15M | 254k | 57.94 |
|
|
Charles River Laboratories (CRL) | 0.2 | $14M | -68% | 73k | 196.97 |
|
Beigene Sponsored Adr | 0.2 | $13M | +129% | 59k | 224.51 |
|
Generation Bio (GBIO) | 0.2 | $9.7M | 3.9M | 2.47 |
|
|
Phreesia (PHR) | 0.2 | $9.6M | -4% | 422k | 22.79 |
|
Humana (HUM) | 0.1 | $9.0M | 28k | 316.74 |
|
|
Terns Pharmaceuticals (TERN) | 0.1 | $8.7M | NEW | 1.0M | 8.34 |
|
Omnicell (OMCL) | 0.1 | $8.6M | -15% | 198k | 43.60 |
|
Abbvie (ABBV) | 0.1 | $8.5M | 43k | 197.48 |
|
|
Johnson & Johnson (JNJ) | 0.1 | $8.3M | +557% | 51k | 162.06 |
|
Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $8.2M | -54% | 169k | 48.73 |
|
Glaukos (GKOS) | 0.1 | $8.2M | +12% | 63k | 130.28 |
|
Amgen (AMGN) | 0.1 | $8.1M | -14% | 25k | 322.21 |
|
Centene Corporation (CNC) | 0.1 | $6.5M | -79% | 87k | 75.28 |
|
10x Genomics Cl A Com (TXG) | 0.1 | $6.4M | -8% | 282k | 22.58 |
|
Illumina (ILMN) | 0.1 | $5.9M | +3% | 45k | 130.41 |
|
Altimmune Com New (ALT) | 0.1 | $5.3M | +43% | 864k | 6.14 |
|
Merck & Co (MRK) | 0.1 | $4.8M | -43% | 42k | 113.56 |
|
Waystar Holding Corp (WAY) | 0.1 | $4.2M | 150k | 27.89 |
|
|
Pfizer (PFE) | 0.1 | $4.1M | +59% | 141k | 28.94 |
|
Gilead Sciences (GILD) | 0.1 | $3.9M | +18% | 46k | 83.84 |
|
Cardinal Health (CAH) | 0.1 | $3.3M | -7% | 30k | 110.52 |
|
Astrazeneca Sponsored Adr (AZN) | 0.0 | $2.6M | -20% | 34k | 77.91 |
|
Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $2.6M | -7% | 393k | 6.59 |
|
Accolade (ACCD) | 0.0 | $2.5M | -23% | 641k | 3.85 |
|
Bristol Myers Squibb (BMY) | 0.0 | $1.9M | NEW | 37k | 51.74 |
|
Encompass Health Corp (EHC) | 0.0 | $1.9M | +38% | 19k | 96.64 |
|
Molecular Templates Com New (MTEM) | 0.0 | $1.8M | 1.3M | 1.41 |
|
|
Dr Reddys Labs Adr (RDY) | 0.0 | $1.6M | -11% | 21k | 79.45 |
|
Summit Therapeutics (SMMT) | 0.0 | $1.4M | NEW | 64k | 21.90 |
|
CVS Caremark Corporation (CVS) | 0.0 | $1.4M | 22k | 62.88 |
|
|
Vaxcyte (PCVX) | 0.0 | $1.4M | -15% | 12k | 114.27 |
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $1.3M | -54% | 71k | 18.02 |
|
Doximity Cl A (DOCS) | 0.0 | $1.3M | -59% | 29k | 43.57 |
|
Certara Ord (CERT) | 0.0 | $1.1M | 96k | 11.71 |
|
|
Biontech Se Sponsored Ads (BNTX) | 0.0 | $1.0M | NEW | 8.7k | 118.77 |
|
Zoetis Cl A (ZTS) | 0.0 | $1.0M | +79% | 5.3k | 195.38 |
|
Viking Therapeutics (VKTX) | 0.0 | $1.0M | +267% | 16k | 63.31 |
|
Alphabet Cap Stk Cl C (GOOG) | 0.0 | $1.0M | 6.0k | 167.19 |
|
|
Tenet Healthcare Corp Com New (THC) | 0.0 | $935k | +3% | 5.6k | 166.20 |
|
Sanofi Sponsored Adr (SNY) | 0.0 | $871k | NEW | 15k | 57.63 |
|
Krystal Biotech (KRYS) | 0.0 | $870k | +13% | 4.8k | 182.03 |
|
Rhythm Pharmaceuticals (RYTM) | 0.0 | $823k | +20% | 16k | 52.39 |
|
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $636k | +21% | 76k | 8.32 |
|
Cytokinetics Com New (CYTK) | 0.0 | $578k | -34% | 11k | 52.80 |
|
Protagonist Therapeutics (PTGX) | 0.0 | $556k | -18% | 12k | 45.00 |
|
Apellis Pharmaceuticals (APLS) | 0.0 | $549k | -95% | 19k | 28.84 |
|
Adma Biologics (ADMA) | 0.0 | $518k | -16% | 26k | 19.99 |
|
Biogen Idec (BIIB) | 0.0 | $511k | -55% | 2.6k | 193.84 |
|
Hutchmed China Sponsored Ads (HCM) | 0.0 | $469k | -97% | 24k | 19.53 |
|
Denali Therapeutics (DNLI) | 0.0 | $457k | NEW | 16k | 29.13 |
|
Viatris (VTRS) | 0.0 | $456k | +48% | 39k | 11.61 |
|
Travere Therapeutics (TVTX) | 0.0 | $434k | NEW | 31k | 13.99 |
|
Merus N V (MRUS) | 0.0 | $400k | -18% | 8.0k | 49.96 |
|
Arcutis Biotherapeutics (ARQT) | 0.0 | $367k | +125% | 40k | 9.30 |
|
Arcellx Common Stock (ACLX) | 0.0 | $334k | NEW | 4.0k | 83.51 |
|
Xenon Pharmaceuticals (XENE) | 0.0 | $323k | -19% | 8.2k | 39.37 |
|
Nike CL B (NKE) | 0.0 | $309k | 3.5k | 88.40 |
|
|
Blueprint Medicines (BPMC) | 0.0 | $296k | -37% | 3.2k | 92.50 |
|
Kura Oncology (KURA) | 0.0 | $266k | +36% | 14k | 19.54 |
|
Bridgebio Pharma (BBIO) | 0.0 | $265k | -18% | 10k | 25.46 |
|
Madrigal Pharmaceuticals (MDGL) | 0.0 | $233k | 1.1k | 212.22 |
|
|
Ideaya Biosciences (IDYA) | 0.0 | $228k | +26% | 7.2k | 31.68 |
|
Ultragenyx Pharmaceutical (RARE) | 0.0 | $222k | 4.0k | 55.55 |
|
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $222k | 4.4k | 50.42 |
|
|
Summit Therapeutics Call Call Option | 0.0 | $219k | NEW | 10k | 21.90 |
|
Baidu Spon Adr Rep A (BIDU) | 0.0 | $211k | 2.0k | 105.29 |
|
|
Mineralys Therapeutics (MLYS) | 0.0 | $200k | -5% | 17k | 12.11 |
|
Garmin SHS (GRMN) | 0.0 | $185k | 1.1k | 176.03 |
|
|
Nurix Therapeutics (NRIX) | 0.0 | $180k | NEW | 8.0k | 22.47 |
|
Rocket Pharmaceuticals (RCKT) | 0.0 | $172k | -52% | 9.3k | 18.47 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $151k | +27% | 42k | 3.63 |
|
Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $128k | NEW | 7.7k | 16.60 |
|
Veracyte (VCYT) | 0.0 | $123k | NEW | 3.6k | 34.04 |
|
Agilent Technologies Inc C ommon (A) | 0.0 | $114k | +9% | 769.00 | 148.48 |
|
Oracle Corporation (ORCL) | 0.0 | $106k | +9% | 624.00 | 170.40 |
|
NVIDIA Corporation (NVDA) | 0.0 | $87k | +9% | 716.00 | 121.44 |
|
Microsoft Corporation (MSFT) | 0.0 | $84k | +8% | 194.00 | 430.30 |
|
Qualcomm (QCOM) | 0.0 | $73k | +9% | 427.00 | 170.05 |
|
Mettler-Toledo International (MTD) | 0.0 | $62k | +2% | 41.00 | 1499.71 |
|
Omniab (OABI) | 0.0 | $49k | 12k | 4.23 |
|
|
Labcorp Holdings Com Shs (LH) | 0.0 | $46k | +8% | 206.00 | 223.48 |
|
Tempus Ai Cl A (TEM) | 0.0 | $29k | -89% | 516.00 | 56.60 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q3 filed Nov. 14, 2024
- Bellevue Group 2024 Q2 filed Aug. 14, 2024
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021